Literature DB >> 26374531

Role of autophagy in the maintenance and function of cancer stem cells.

Ilio Vitale1, Gwenola Manic, Vito Dandrea, Ruggero De Maria.   

Abstract

Recent advances in experimental technologies and cancer models have made possible to demonstrate that the tumor is a dynamic system comprising heterogeneous populations of cancer cells organized in a hierarchical fashion with cancer stem cells (CSCs) at the apex. CSCs are immature cells characterized by self-renewal property and long-term repopulation potential. CSCs have been causally linked to cancer initiation, propagation, spreading, recurrence and relapse as well as to resistance to anticancer therapy. A growing body of evidence suggests that the function and physiology of CSCs may be influenced by genetic/epigenetic factors and tumor environment. In this context, macroautophagy is a lysosomal degradative process (herein referred to as autophagy) critical for the adaptive response to stress and the preservation of cellular and tissue homeostasis in all eukaryotes that may have a crucial role of in the origin, maintenance and invasiveness of CSCs. The activation of the autophagic machinery is also considered as an adaptive response of CSCs to perturbation of tumor microenvironment, caused for instance by anticancer therapy. Nevertheless, compelling preclinical and clinical evidence on the cytoprotective role of autophagy for CSCs is still missing. Here, we summarize the results on the contribution of autophagy in CSCs and how it impacts tumorigenesis and tumor progression. We also discuss the therapeutical potential of the modulation of autophagy as a means to eradicate CSCs.

Entities:  

Mesh:

Year:  2015        PMID: 26374531     DOI: 10.1387/ijdb.150082iv

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  18 in total

1.  Transcription factor EB is involved in autophagy-mediated chemoresistance to doxorubicin in human cancer cells.

Authors:  Li-Mei Fang; Bin Li; Jun-Jie Guan; Hai-Dong Xu; Gen-Hai Shen; Quan-Gen Gao; Zheng-Hong Qin
Journal:  Acta Pharmacol Sin       Date:  2017-06-12       Impact factor: 6.150

Review 2.  Inflammatory networks underlying colorectal cancer.

Authors:  Audrey Lasry; Adar Zinger; Yinon Ben-Neriah
Journal:  Nat Immunol       Date:  2016-03       Impact factor: 25.606

3.  Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.

Authors:  Oriana Lo Re; Julien Douet; Marcus Buschbeck; Caterina Fusilli; Valerio Pazienza; Concetta Panebianco; Carlo Castruccio Castracani; Tommaso Mazza; Giovanni Li Volti; Manlio Vinciguerra
Journal:  Epigenetics       Date:  2018-09-29       Impact factor: 4.528

Review 4.  Drug repurposing for the treatment of glioblastoma multiforme.

Authors:  Claudia Abbruzzese; Silvia Matteoni; Michele Signore; Luca Cardone; Kavindra Nath; Jerry D Glickson; Marco G Paggi
Journal:  J Exp Clin Cancer Res       Date:  2017-11-28

5.  ATM kinase sustains breast cancer stem-like cells by promoting ATG4C expression and autophagy.

Authors:  Martina Antonelli; Flavie Strappazzon; Ivan Arisi; Rossella Brandi; Mara D'Onofrio; Manolo Sambucci; Gwenola Manic; Ilio Vitale; Daniela Barilà; Venturina Stagni
Journal:  Oncotarget       Date:  2017-03-28

Review 6.  Fate of Antibody-Drug Conjugates in Cancer Cells.

Authors:  Cécile Chalouni; Sophia Doll
Journal:  J Exp Clin Cancer Res       Date:  2018-02-06

7.  p53 balances between tissue hierarchy and anarchy.

Authors:  Gabriela Koifman; Ronit Aloni-Grinstein; Varda Rotter
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

8.  Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres.

Authors:  Hee Yeon Kim; Byung Il Lee; Ji Hoon Jeon; Dong Keon Kim; Seok-Gu Kang; Jin-Kyoung Shim; Soo Youl Kim; Sang Won Kang; Hyonchol Jang
Journal:  Biomolecules       Date:  2019-10-10

Review 9.  Drug repurposing against COVID-19: focus on anticancer agents.

Authors:  Gennaro Ciliberto; Rita Mancini; Marco G Paggi
Journal:  J Exp Clin Cancer Res       Date:  2020-05-12

10.  Improved detection of differentially represented DNA barcodes for high-throughput clonal phenomics.

Authors:  Yevhen Akimov; Daria Bulanova; Sanna Timonen; Krister Wennerberg; Tero Aittokallio
Journal:  Mol Syst Biol       Date:  2020-03       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.